Microscopic Colitis: Epidemiology, Pathophysiology, Diagnosis and Current Management—An Update 2013

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td align="left">Confirm diagnosis/rule out other disorders</td></tr><tr><td align="left">Withdrawal of medications associated with microscopic colitis</td></tr><tr><td align="left">Dietary changes (avoid caffeine, lactose)</td></tr><tr><td align="left">Trial of loperamide (mild symptoms)</td></tr><tr><td align="left">Trial of budesonide (moderate symptoms)</td></tr><tr><td align="left"> (a) Induction of remission</td></tr><tr><td align="left"> (b) Maintenance of remission</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

International Scholarly Research Notices

tab3

Table 3

Table 3: Microscopic Colitis: Epidemiology, Pathophysiology, Diagnosis and Current Management—An Update 2013 